Correlation Between Immunovant and Day One

Can any of the company-specific risk be diversified away by investing in both Immunovant and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunovant and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immunovant and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Immunovant and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunovant with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunovant and Day One.

Diversification Opportunities for Immunovant and Day One

0.05

Correlation Coefficient

Immunovant  Day One

Significant diversification

The 3 months correlation between Immunovant and Day is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Immunovant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunovant are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Immunovant i.e., Immunovant and Day One go up and down completely randomly.

Pair Corralation between Immunovant and Day One

Given the investment horizon of 90 days Immunovant is expected to generate 0.93 times more return on investment than Day One. However, Immunovant is 1.08 times less risky than Day One. It trades about 0.15 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.11 per unit of risk. If you would invest  2,851  in Immunovant on July 30, 2024 and sell it today you would earn a total of  171.00  from holding Immunovant or generate 6.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Immunovant  vs.  Day One Biopharmaceuticals

Immunovant

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Immunovant are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Immunovant may actually be approaching a critical reversion point that can send shares even higher in November 2024.

Day One Biopharmaceu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Immunovant and Day One

The main advantage of trading using opposite Immunovant and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunovant position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.

The idea behind Immunovant and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.